Image

North America Artificial Intelligence (AI) in Drug Discovery Market – Industry Trends and Forecast to 2031

Healthcare

Image

North America Artificial Intelligence (AI) in Drug Discovery Market – Industry Trends and Forecast to 2031

  • Healthcare
  • Upcoming Report
  • May 2024
  • North America
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

North America Artificial Intelligence (AI) in Drug Discovery Market – Industry Trends and Forecast to 2031

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2023–2031
Diagram Market Size (Base Year) USD 1.07 USD Billion
Diagram Market Size (Forecast Year) USD 9.88 USD Billion
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

North America Artificial Intelligence (AI) in Drug Discovery Market, By Application (Novel Drug Candidates, Drug Optimization and Repurposing Preclinical Testing and Approval, Drug Monitoring, Finding New Diseases Associated Targets and Pathways, Understanding Disease Mechanisms, Aggregating and Synthesizing Information, Formation and Qualification of Hypotheses, De Novo Drug Design, Finding Drug Targets of an Old Drug and Others), Technology (Machine Learning, Deep Learning, Natural Language Processing and Others), Drug Type (Small Molecule and Large Molecule), Offering (Software and Services), Indication (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases and Others), End Use (Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Research Centers and Academic Institutes and Others) – Industry Trends and Forecast to 2031.

North America Artificial Intelligence (AI) in Drug Discovery Market

North America Artificial Intelligence (AI) in Drug Discovery Market Analysis and Size

Artificial intelligence (AI) in the drug discovery market has seen remarkable advancement, revolutionizing processes through data analysis, predictive modeling, and virtual screening. Its benefits include accelerated drug development, cost reduction, and increased precision in target identification. AI optimizes lead compounds, streamlines clinical trials, and enhances personalized medicine, promising novel therapies for various diseases while minimizing risks and time-to-market.                                

North America artificial intelligence (AI) in drug discovery market size was valued at USD 1.07 billion in 2023, is projected to reach USD 9.88 billion by 2031, with a CAGR of 54.9% during the forecast period 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Application (Novel Drug Candidates, Drug Optimization and Repurposing Preclinical Testing and Approval, Drug Monitoring, Finding New Diseases Associated Targets and Pathways, Understanding Disease Mechanisms, Aggregating and Synthesizing Information, Formation and Qualification of Hypotheses, De Novo Drug Design, Finding Drug Targets of an Old Drug and Others), Technology (Machine Learning, Deep Learning, Natural Language Processing and Others), Drug Type (Small Molecule and Large Molecule), Offering (Software and Services), Indication (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases and Others), End Use (Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Research Centers and Academic Institutes and Others)

Countries Covered

U.S., Canada and Mexico

Market Players Covered

NVIDIA Corporation (U.S.), IBM Corp. (U.S.), Atomwise Inc. (U.S.), Microsoft (U.S.), Benevolent AI (U.K.), Aria Pharmaceuticals, Inc. (U.S.), DEEP GENOMICS (Canada), Exscientia (U.K.), Insilico Medicine (Hong Kong), Cyclica (Canada), NuMedii, Inc. (U.S.), Envisagenics (U.S.), Owkin Inc. (U.S.), BERG LLC (U.S.), Schrödinger, Inc. (U.S.), XtalPi Inc. (China), and BIOAGE Inc. (U.S.)

Market Opportunities

  • Growing Collaboration and Data Sharing among Researchers
  • Growing Demand for Personalized Medicine

Market Definition

Artificial intelligence (AI) in drug discovery employs algorithms and machine learning to expedite the identification and development of potential pharmaceutical compounds. By analyzing vast datasets, AI models predict molecular interactions, optimize drug designs, and forecast biological activity, significantly accelerating the discovery process. AI-driven approaches enhance efficiency, precision, and innovation in drug development, offering promising solutions to complex healthcare challenges.           

Artificial Intelligence (AI) in Drug Discovery Market Dynamics

Drivers

  • Accelerated Drug Discovery Process

AI expedites the drug discovery process by analyzing vast datasets, predicting molecular interactions, and identifying potential drug candidates more rapidly than traditional methods.  For instance, Atomwise, using AI-powered virtual screening, identified a drug candidate for Ebola in just a few days, a process that typically takes months using traditional methods. This acceleration allows for quicker identification and development of promising compounds, potentially saving lives in urgent medical situations.

  • Rise in Incidence of Chronic Diseases Propels Need

The surge in chronic diseases worldwide, exemplified by CDC data showing six in 10 U.S. adults affected, underscores the urgency for effective treatments. AI in drug discovery emerges as a promising solution to mitigate this health crisis. Through analyzing vast datasets, AI platforms offer insights into developing drugs targeting conditions such as heart disease and diabetes, addressing the pressing need for innovative therapies to reduce mortality rates.

Opportunities

  • Rising Collaboration and Data Sharing among Researchers

AI fosters collaboration among researchers and facilitates data sharing across institutions and companies, enabling access to diverse datasets and enhancing the collective knowledge base for drug discovery. For instance, platforms such as OpenAI's Drug Discovery, which harness AI to analyze molecular structures and predict drug properties, encourage collaborative efforts by providing a shared space for researchers to access and contribute to a vast pool of data, accelerating the pace of discovery and innovation in the pharmaceutical industry.

  • Growing Demand for Personalized Medicine

AI facilitates personalized medicine by analyzing patient data, including genomics, proteomics, and clinical records, to identify biomarkers indicative of disease susceptibility and treatment response. For instance, AI-driven analysis of tumor genomic profiles can predict patient responses to specific cancer therapies, enabling tailored treatment strategies that maximize efficacy and minimize adverse effects, ultimately improving patient outcomes in oncology and beyond. 

Restraints/Challenges

  • Integration with Traditional Methods Hinder Workflow

Integrating AI with traditional drug discovery methods faces hurdles in standardization, compatibility, and workflow optimization. Harmonizing AI algorithms with established experimental and computational techniques necessitates meticulous planning to ensure seamless integration, minimizing disruptions to existing workflows.

  • Data Privacy and Accessibility Limit Development

Access to proprietary data in drug discovery is restricted due to privacy, intellectual property, and regulatory constraints. This limits the availability of data for AI models, hindering their development and validation. Privacy concerns, especially regarding patient data, necessitate careful handling and compliance with regulations, further complicating data accessibility for AI-driven drug discovery initiatives.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In July 2021, Chief.AI introduced a pay-as-you-go AI platform for drug discovery, democratizing access to advanced AI technologies. This empowers small and medium enterprises to pinpoint breakthrough therapeutics swiftly and precisely, addressing the unpredictability of traditional drug discovery
  • In January 2021, Nucleai and Debiopharm Pharma formed a collaborative agreement, permitting the latter to utilize Nucleai's AI platform for oncology drug candidates. This underscores AI's growing significance in refining drug development processes, particularly in biomarker-based therapies
  • In September 2020 witnessed Atomwise securing USD 123 million in Series B financing, led by Sanabil and B Capital Group Investments. This substantial investment aims to expand Atomwise's market presence, initiate its drug discovery pipeline, and forge new partnerships with pharmaceutical firms, emphasizing AI's pivotal role in advancing artificial intelligence in drug discovery and development
  • In July 2020, IBM strategically acquired WDG Automation, enriching its AI-infused automation capabilities for enterprises. This strategic move enhances IBM's capacity to deliver comprehensive AI solutions, spanning from business processes to IT operations, thereby fortifying its overall portfolio

Artificial Intelligence (AI) in Drug Discovery Market Scope

The market is segmented on the basis of application, technology, drug type, offering, indication, and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

  • Novel Drug Candidates
  • Drug Optimization and Repurposing Preclinical Testing and Approval
  • Drug Monitoring
  • Finding New Diseases Associated Targets and Pathways
  • Understanding Disease Mechanisms
  • Aggregating and Synthesizing Information
  • Formation and Qualification of Hypotheses
  • De Novo Drug Design
  • Finding Drug Targets of an Old Drug
  • Others

 Technology

  • Machine Learning
  • Deep Learning
  • Natural Language Processing
  • Others

 Drug Type

  • Small Molecule
  • Large Molecule

 Offering

  • Software
  • Services

 Indication

  • Immuno-Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Others

 End Use

  • Contract Research Organizations (CROs)
  • Pharmaceutical and Biotechnology Companies
  • Research Centers and Academic Institutes
  • Others

North America Artificial Intelligence (AI) in Drug Discovery Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, application, technology, drug type, offering, indication, and end use as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America.

U.S. dominates the artificial intelligence in drug discovery market, propelled by key market players and its status as the largest consumer market with a high GDP. The country's growth is fueled by advancing AI technologies tailored for drug discovery applications.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Artificial Intelligence (AI) in Drug Discovery Market Share Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

  • NVIDIA Corporation (U.S.)
  • IBM Corp. (U.S.)
  • Atomwise Inc. (U.S.)
  • Microsoft (U.S.)
  • Benevolent AI (U.K.)
  • Aria Pharmaceuticals, Inc. (U.S.)
  • DEEP GENOMICS (Canada)
  • Exscientia (U.K.)
  • Insilico Medicine (Hong Kong)
  • Cyclica (Canada)
  • NuMedii, Inc. (U.S.)
  • Envisagenics (U.S.)
  • Owkin Inc. (U.S.)
  • BERG LLC (U.S.)
  • Schrödinger, Inc. (U.S.)
  • XtalPi Inc. (China)
  • BIOAGE Inc. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

Accelerated Drug Discovery Process and Rise in Incidence of Chronic Diseases Propels Need are the growth drivers of the North America Artificial Intelligence (AI) in Drug Discovery Market.
The application, technology, drug type, offering, indication, and end use are the factors on which the North America Artificial Intelligence (AI) in Drug Discovery Market research is based.
The major companies in the North America Artificial Intelligence (AI) in Drug Discovery Market are NVIDIA Corporation (U.S.), IBM Corp. (U.S.), Atomwise Inc. (U.S.), Microsoft (U.S.), Benevolent AI (U.K.), Aria Pharmaceuticals, Inc. (U.S.), DEEP GENOMICS (Canada), Exscientia (U.K.), Insilico Medicine (Hong Kong), Cyclica (Canada), NuMedii, Inc. (U.S.), Envisagenics (U.S.), Owkin Inc. (U.S.), BERG LLC (U.S.), Schrödinger, Inc. (U.S.), XtalPi Inc. (China), and BIOAGE Inc. (U.S.).
The North America Artificial Intelligence (AI) in Drug Discovery Market size will be worth USD 9.88 billion by 2031.
The North America Artificial Intelligence (AI) in Drug Discovery Market growth rate will be 54.9% by 2031.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials